Symbols / AIRS Stock $5.33 +1.33% AirSculpt Technologies, Inc.

Healthcare • Medical Care Facilities • United States • NGM
AIRS (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Medical Care Facilities
CEO Mr. Yogesh Jashnani
Exch · Country NGM · United States
Market Cap 376.01M
Enterprise Value 430.33M
Income -11.22M
Sales 151.84M
FCF (ttm) 13.02M
Book/sh 1.42
Cash/sh 0.24
Employees 330
Insider 10d —
IPO Oct 29, 2021
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E -266.50
PEG —
P/S 2.48
P/B 3.75
P/C —
EV/EBITDA 57.27
EV/Sales 2.83
Quick Ratio 0.57
Current Ratio 0.75
Debt/Eq 70.83
LT Debt/Eq —
EPS (ttm) -0.17
EPS next Y -0.02
EPS Growth —
Revenue Growth 0.00%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-08-07
Earnings (prior) 2026-05-08
ROA -1.60%
ROE -12.63%
ROIC —
Gross Margin 66.06%
Oper. Margin -4.58%
Profit Margin -7.39%
Shs Outstand 70.55M
Shs Float 9.96M
Insider Own 43.06%
Instit Own 66.04%
Short Float 11.05%
Short Ratio 3.23
Short Interest 4.37M
52W High 12.00
vs 52W High -55.58%
52W Low 1.51
vs 52W Low 252.98%
Beta 2.02
Impl. Vol. 1.49%
Rel Volume 0.37
Avg Volume 2.79M
Volume 1.02M
Target (mean) $4.50
Tgt Median $4.50
Tgt Low $4.50
Tgt High $4.50
# Analysts 1
Recom Hold
Prev Close $5.26
Price $5.33
Change 1.33%
About

AirSculpt Technologies, Inc., together with its subsidiaries, focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States and Canada. The company offers AirSculpt, a body contouring treatment that removes fat and tightens skin while sculpting targeted areas of the body in a minimally invasive procedure. It also provides AirSculpt+, a procedure that permanently removes fat and tightens the skin with unparalleled precision and finesse; and AirSculpt Smooth, an advanced cellulite removal tool. In addition, it provides fat removal procedures across treatment areas, such as the stomach, back, and buttocks; and fat transfer procedures that transfers the patient's own fat cells to enhance the buttocks, breasts, hips, aging hands, or other areas. Further, the company's body contouring procedures include the Power BBL, a Brazilian butt lift procedure; the Up a Cup, a breast enhancement procedure; and the Hip Flip, an hourglass contouring procedure. Additionally, it operates various centers. The company was founded in 2012 and is headquartered in Miami Beach, Florida.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$4.50
Mean price target
2. Current target
$5.33
Latest analyst target
3. DCF / Fair value
$3.32
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$5.33
Low
$4.50
High
$4.50
Mean
$4.50

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2025-03-31 main Leerink Partners Market Perform → Market Perform $3
2025-01-17 main Piper Sandler Neutral → Neutral $5
2025-01-06 main Piper Sandler Neutral → Neutral $6
2024-10-17 init BTIG — → Neutral —
2024-05-14 down Leerink Partners Outperform → Market Perform $5
2023-11-16 main Morgan Stanley Equal-Weight → Equal-Weight $6
2023-08-22 main Morgan Stanley Equal-Weight → Equal-Weight $8
2023-08-21 main Morgan Stanley Equal-Weight → Equal-Weight $8
2023-08-01 main Raymond James Outperform → Outperform $10
2023-03-13 main Raymond James — → Outperform $8
2023-01-17 main Morgan Stanley — → Equal-Weight $6
2022-11-15 main Morgan Stanley — → Equal-Weight $7
2022-11-14 main Raymond James — → Outperform $10
2022-11-14 main SVB Leerink — → Outperform $8
2022-08-24 main Morgan Stanley — → Equal-Weight $11
2022-06-16 down Morgan Stanley Overweight → Equal-Weight $9
2022-03-14 main SVB Leerink — → Outperform $27
2021-11-23 init Raymond James — → Outperform $18
2021-11-23 init Morgan Stanley — → Overweight $17
2021-11-23 init SVB Leerink — → Outperform $26
News
RSS: Latest AIRS news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-05-12 AARON THOMAS J. Director — 100,286 $0.00 $0
2026-05-12 CHU CAROLINE Director — 100,286 $0.00 $0
2026-05-12 HIGGINS KENNETH Director — 100,286 $0.00 $0
2026-04-08 WADMAN BRENT R General Counsel — 55,272 $0.00 $0
2026-04-08 ARTHUR MICHAEL J Chief Financial Officer — 68,027 $0.00 $0
2026-04-08 JASHNANI YOGESH Chief Executive Officer — 238,095 $0.00 $0
2026-03-11 CHERNETT JOREY Beneficial Owner of more than 10% of a Class of Security — 88,000 $2.15 $189,200
2026-03-06 CHERNETT JOREY Beneficial Owner of more than 10% of a Class of Security — 45,600 $2.00 $91,200
2026-03-04 CHERNETT JOREY Beneficial Owner of more than 10% of a Class of Security — 110,000 $1.71 $192,900
2026-01-23 ARTHUR MICHAEL J Chief Financial Officer — 147,059 $0.00 $0
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
151.82
-15.82%
180.35
-7.95%
195.92
+16.07%
168.79
Operating Revenue
151.82
-15.82%
180.35
-7.95%
195.92
+16.07%
168.79
Cost Of Revenue
61.69
-13.29%
71.15
-3.56%
73.77
+17.51%
62.78
Reconciled Cost Of Revenue
61.69
-13.29%
71.15
-3.56%
73.77
+17.51%
62.78
Gross Profit
90.13
-17.47%
109.20
-10.60%
122.14
+15.22%
106.01
Operating Expense
94.96
-14.27%
110.77
-1.66%
112.63
+2.88%
109.48
Selling General And Administration
82.18
-16.89%
98.88
-3.42%
102.38
+0.95%
101.42
Total Expenses
156.65
-13.89%
181.92
-2.41%
186.41
+8.21%
172.26
Operating Income
-4.83
-208.42%
-1.57
-116.48%
9.51
+374.38%
-3.47
Total Operating Income As Reported
-11.56
-630.26%
-1.58
-116.28%
9.72
+313.91%
-4.54
EBITDA
1.22
-88.15%
10.30
-48.41%
19.98
+468.12%
3.52
Normalized EBITDA
7.95
-22.99%
10.32
-47.78%
19.76
+330.10%
4.59
Reconciled Depreciation
12.78
+7.51%
11.89
+15.95%
10.25
+27.19%
8.06
EBIT
-11.56
-630.26%
-1.58
-116.28%
9.72
+313.91%
-4.54
Total Unusual Items
-6.73
-41943.75%
-0.02
-107.55%
0.21
+119.65%
-1.08
Total Unusual Items Excluding Goodwill
-6.73
-41943.75%
-0.02
-107.55%
0.21
+119.65%
-1.08
Special Income Charges
-6.73
-41943.75%
-0.02
-107.55%
0.21
+119.65%
-1.08
Other Special Charges
—
—
—
0.93
Impairment Of Capital Assets
4.58
+28493.75%
0.02
+107.55%
-0.21
-244.22%
0.15
Net Income
-11.67
-45.51%
-8.02
-89.10%
-4.24
+71.12%
-14.68
Pretax Income
-17.64
-125.26%
-7.83
-341.89%
3.24
+128.66%
-11.30
Net Non Operating Interest Income Expense
-6.08
+2.71%
-6.25
+3.67%
-6.49
+3.94%
-6.75
Interest Expense Non Operating
6.08
-2.71%
6.25
-3.67%
6.49
-3.94%
6.75
Net Interest Income
-6.08
+2.71%
-6.25
+3.67%
-6.49
+3.94%
-6.75
Interest Expense
6.08
-2.71%
6.25
-3.67%
6.49
-3.94%
6.75
Other Income Expense
-6.73
-41943.75%
-0.02
-107.55%
0.21
+119.65%
-1.08
Gain On Sale Of Business
-2.15
—
—
—
Tax Provision
-5.97
-3276.06%
0.19
-97.49%
7.48
+121.02%
3.38
Tax Rate For Calcs
0.00
+60.95%
0.00
+0.00%
0.00
+0.00%
0.00
Tax Effect Of Unusual Items
-2.27
-67570.42%
-0.00
-107.55%
0.04
+119.65%
-0.23
Net Income Including Noncontrolling Interests
-11.67
-45.51%
-8.02
-89.10%
-4.24
+71.12%
-14.68
Net Income From Continuing Operation Net Minority Interest
-11.67
-45.51%
-8.02
-89.10%
-4.24
+71.12%
-14.68
Net Income From Continuing And Discontinued Operation
-11.67
-45.51%
-8.02
-89.10%
-4.24
+71.12%
-14.68
Net Income Continuous Operations
-11.67
-45.51%
-8.02
-89.10%
-4.24
+71.12%
-14.68
Normalized Income
-7.21
+9.89%
-8.01
-81.63%
-4.41
+68.12%
-13.83
Net Income Common Stockholders
-11.67
-45.51%
-8.02
-89.10%
-4.24
+71.12%
-14.68
Otherunder Preferred Stock Dividend
—
—
0.00
0.00
Diluted EPS
-0.19
-35.71%
-0.14
-75.00%
-0.08
+69.23%
-0.26
Basic EPS
-0.19
-35.71%
-0.14
-75.00%
-0.08
+69.23%
-0.26
Basic Average Shares
60.45
+4.79%
57.69
+1.60%
56.78
+1.96%
55.68
Diluted Average Shares
60.45
+4.79%
57.69
+1.60%
56.78
+1.96%
55.68
Diluted NI Availto Com Stockholders
-11.67
-45.51%
-8.02
-89.10%
-4.24
+71.12%
-14.68
Depreciation Amortization Depletion Income Statement
12.78
+7.51%
11.89
+15.95%
10.25
+27.19%
8.06
Depreciation And Amortization In Income Statement
12.78
+7.51%
11.89
+15.95%
10.25
+27.19%
8.06
Gain On Sale Of PPE
—
-0.02
-107.55%
0.21
+244.22%
-0.15
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
187.30
-11.97%
212.78
+4.29%
204.02
+1.62%
200.76
Current Assets
15.46
-9.70%
17.12
+7.24%
15.96
-4.29%
16.68
Cash Cash Equivalents And Short Term Investments
8.45
+2.60%
8.23
-19.75%
10.26
+6.72%
9.62
Cash And Cash Equivalents
8.45
+2.60%
8.23
-19.75%
10.26
+6.72%
9.62
Receivables
1.50
-50.95%
3.06
+57.44%
1.94
-31.44%
2.83
Taxes Receivable
1.50
-50.95%
3.06
+57.44%
1.94
-31.44%
2.83
Prepaid Assets
—
—
—
—
Other Current Assets
5.51
-5.46%
5.83
+55.03%
3.76
-11.14%
4.23
Total Non Current Assets
171.85
-12.17%
195.66
+4.04%
188.06
+2.16%
184.08
Net PPE
50.27
-24.87%
66.91
+23.18%
54.32
+13.24%
47.97
Gross PPE
75.91
-11.26%
85.54
+29.57%
66.02
+21.93%
54.15
Accumulated Depreciation
-25.64
-37.60%
-18.63
-59.25%
-11.70
-89.44%
-6.18
Properties
0.00
0.00
0.00
0.00
Machinery Furniture Equipment
5.51
-8.33%
6.01
+17.00%
5.14
+28.24%
4.01
Construction In Progress
2.42
+7.64%
2.25
+17.85%
1.91
-33.08%
2.85
Other Properties
35.53
-17.39%
43.01
+16.27%
36.99
+13.22%
32.67
Leases
32.44
-5.34%
34.27
+55.90%
21.98
+50.42%
14.61
Goodwill And Other Intangible Assets
118.57
-3.85%
123.33
-3.71%
128.08
-3.58%
132.83
Goodwill
81.73
+0.00%
81.73
+0.00%
81.73
+0.00%
81.73
Other Intangible Assets
36.84
-11.43%
41.59
-10.26%
46.35
-9.30%
51.10
Other Non Current Assets
3.01
-44.60%
5.43
-4.05%
5.66
+72.47%
3.28
Total Liabilities Net Minority Interest
99.59
-26.01%
134.59
+12.14%
120.03
-7.67%
129.99
Current Liabilities
27.90
-3.62%
28.95
+42.50%
20.32
-8.97%
22.32
Payables And Accrued Expenses
13.27
-22.34%
17.09
+50.55%
11.35
-15.78%
13.48
Payables
5.37
-14.19%
6.26
+59.51%
3.92
+2.03%
3.84
Accounts Payable
5.37
-14.19%
6.26
+59.51%
3.92
+2.03%
3.84
Current Accrued Expenses
7.91
-27.04%
10.84
+45.83%
7.43
-22.89%
9.63
Current Debt And Capital Lease Obligation
12.76
+19.36%
10.69
+42.52%
7.50
+15.72%
6.48
Current Debt
5.46
+28.47%
4.25
+100.00%
2.12
+0.00%
2.12
Other Current Borrowings
5.46
+28.47%
4.25
+100.00%
2.12
+0.00%
2.12
Current Capital Lease Obligation
7.30
+13.34%
6.44
+19.80%
5.38
+23.39%
4.36
Current Deferred Liabilities
1.87
+60.05%
1.17
-20.10%
1.46
-37.96%
2.36
Current Deferred Revenue
1.87
+60.05%
1.17
-20.10%
1.46
-37.96%
2.36
Total Non Current Liabilities Net Minority Interest
71.69
-32.14%
105.64
+5.95%
99.71
-7.40%
107.67
Long Term Debt And Capital Lease Obligation
70.81
-27.93%
98.25
+6.60%
92.17
-8.89%
101.17
Long Term Debt
50.59
-28.20%
70.46
+1.37%
69.50
-14.64%
81.42
Long Term Capital Lease Obligation
20.23
-27.23%
27.80
+22.63%
22.66
+14.79%
19.75
Non Current Deferred Liabilities
0.88
-86.65%
6.58
-3.69%
6.83
+24.48%
5.49
Non Current Deferred Taxes Liabilities
0.88
-86.65%
6.58
-3.69%
6.83
+24.48%
5.49
Other Non Current Liabilities
—
0.82
+14.11%
0.72
-30.15%
1.02
Stockholders Equity
87.71
+12.18%
78.19
-6.91%
83.99
+18.69%
70.77
Common Stock Equity
87.71
+12.18%
78.19
-6.91%
83.99
+18.69%
70.77
Capital Stock
0.06
+10.34%
0.06
+1.75%
0.06
+1.79%
0.06
Common Stock
0.06
+10.34%
0.06
+1.75%
0.06
+1.79%
0.06
Share Issued
64.54
+10.58%
58.37
+1.77%
57.36
+2.09%
56.18
Ordinary Shares Number
64.54
+10.58%
58.37
+1.77%
57.36
+2.09%
56.18
Additional Paid In Capital
128.31
+19.12%
107.72
+3.68%
103.90
+21.01%
85.86
Retained Earnings
-40.57
-40.36%
-28.90
-47.84%
-19.55
-29.72%
-15.07
Gains Losses Not Affecting Retained Earnings
-0.10
+86.03%
-0.69
-66.75%
-0.41
-442.11%
-0.08
Other Equity Adjustments
-0.10
+86.03%
-0.69
-66.75%
-0.41
-442.11%
-0.08
Total Equity Gross Minority Interest
87.71
+12.18%
78.19
-6.91%
83.99
+18.69%
70.77
Total Capitalization
138.30
-6.96%
148.64
-3.16%
153.50
+0.86%
152.19
Working Capital
-12.45
-5.19%
-11.83
-171.75%
-4.35
+22.83%
-5.64
Invested Capital
143.76
-5.98%
152.89
-1.75%
155.62
+0.85%
154.31
Total Debt
83.57
-23.29%
108.94
+9.30%
99.67
-7.41%
107.65
Net Debt
47.60
-28.40%
66.47
+8.32%
61.37
-16.99%
73.93
Capital Lease Obligations
27.52
-19.60%
34.23
+22.09%
28.04
+16.34%
24.10
Net Tangible Assets
-30.86
+31.63%
-45.14
-2.38%
-44.09
+28.97%
-62.07
Tangible Book Value
-30.86
+31.63%
-45.14
-2.38%
-44.09
+28.97%
-62.07
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
3.10
-72.72%
11.35
-52.62%
23.96
-2.01%
24.45
Cash Flow From Continuing Operating Activities
3.10
-72.72%
11.35
-52.62%
23.96
-2.01%
24.45
Net Income From Continuing Operations
-11.67
-45.51%
-8.02
-89.10%
-4.24
+71.12%
-14.68
Depreciation Amortization Depletion
12.78
+7.51%
11.89
+15.95%
10.25
+27.19%
8.06
Depreciation And Amortization
12.78
+7.51%
11.89
+15.95%
10.25
+27.19%
8.06
Other Non Cash Items
2.68
+689.68%
0.34
+63.77%
0.21
-77.52%
0.92
Stock Based Compensation
2.33
-38.04%
3.76
-79.36%
18.22
-38.13%
29.46
Deferred Tax
-5.91
-2246.83%
-0.25
-118.78%
1.34
+18.34%
1.13
Deferred Income Tax
-5.91
-2246.83%
-0.25
-118.78%
1.34
+18.34%
1.13
Operating Gains Losses
4.58
+28493.75%
0.02
+107.55%
-0.21
-119.65%
1.08
Gain Loss On Sale Of PPE
4.58
+28493.75%
0.02
+107.55%
-0.21
-244.22%
0.15
Change In Working Capital
-1.69
-146.67%
3.62
+323.42%
-1.62
-6.03%
-1.53
Change In Receivables
1.56
+239.55%
-1.11
-225.28%
0.89
+131.44%
-2.83
Change In Prepaid Assets
-4.44
-115.64%
-2.06
-541.85%
0.47
+9420.00%
-0.01
Change In Payables And Accrued Expense
-6.21
-162.29%
9.96
+278.43%
2.63
-70.86%
9.04
Change In Accrued Expense
-6.79
-173.56%
9.22
+224.94%
2.84
-65.26%
8.17
Change In Payable
0.58
-21.65%
0.74
+458.74%
-0.21
-123.82%
0.86
Change In Account Payable
0.58
-21.65%
0.74
+458.74%
-0.21
-123.82%
0.86
Change In Other Working Capital
0.73
+350.85%
-0.29
+67.30%
-0.90
-98.23%
-0.45
Change In Other Current Assets
6.67
+331.40%
-2.88
+38.82%
-4.71
+35.24%
-7.27
Investing Cash Flow
-2.40
+82.84%
-14.01
-41.21%
-9.92
+23.23%
-12.92
Cash Flow From Continuing Investing Activities
-2.40
+82.84%
-14.01
-41.21%
-9.92
+23.23%
-12.92
Net PPE Purchase And Sale
-2.40
+82.84%
-14.01
-41.21%
-9.92
+23.23%
-12.92
Purchase Of PPE
-2.40
+82.84%
-14.01
-41.21%
-9.92
+23.23%
-12.92
Capital Expenditure
-2.40
+82.84%
-14.01
-41.21%
-9.92
+23.23%
-12.92
Financing Cash Flow
-0.48
-175.87%
0.63
+104.70%
-13.39
+50.87%
-27.26
Cash Flow From Continuing Financing Activities
-0.48
-175.87%
0.63
+104.70%
-13.39
+50.87%
-27.26
Net Issuance Payments Of Debt
-18.79
-753.67%
2.88
+123.71%
-12.12
-1495.39%
-0.76
Issuance Of Debt
—
5.00
0.00
-100.00%
83.50
Repayment Of Debt
-18.79
-784.38%
-2.12
+82.47%
-12.12
+85.61%
-84.26
Long Term Debt Issuance
—
5.00
0.00
-100.00%
83.50
Long Term Debt Payments
-18.79
-784.38%
-2.12
+82.47%
-12.12
+85.61%
-84.26
Net Long Term Debt Issuance
-18.79
-753.67%
2.88
+123.71%
-12.12
-1495.39%
-0.76
Net Common Stock Issuance
18.76
0.00
0.00
0.00
Common Stock Dividend Paid
0.00
+100.00%
-0.25
+45.69%
-0.46
+98.09%
-24.32
Cash Dividends Paid
0.00
+100.00%
-0.25
+45.69%
-0.46
+98.09%
-24.32
Net Other Financing Charges
-0.45
+77.47%
-1.99
-148.50%
-0.80
+63.18%
-2.18
Changes In Cash
0.21
+110.56%
-2.03
-413.78%
0.65
+104.11%
-15.73
Beginning Cash Position
8.23
-19.75%
10.26
+6.72%
9.62
-62.06%
25.35
End Cash Position
8.45
+2.60%
8.23
-19.75%
10.26
+6.72%
9.62
Free Cash Flow
0.69
+126.04%
-2.66
-118.93%
14.04
+21.79%
11.53
Interest Paid Supplemental Data
5.56
-7.25%
6.00
-4.46%
6.28
+7.67%
5.83
Income Tax Paid Supplemental Data
—
1.81
-61.23%
4.66
-5.45%
4.93
Common Stock Issuance
18.76
0.00
0.00
0.00
Issuance Of Capital Stock
18.76
0.00
0.00
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category